STAMPEDE Trial
-
Abiraterone: England Expands Access to Life-Extending Prostate Cancer Drug, Ending ‘Postcode Lottery’
Thousands of men in England with high-risk prostate cancer will now have access to the life-extending drug Abiraterone, previously limited by cost and regional disparities. This move, championed by patient advocates and charities, promises to save thousands of lives and…